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Glomerulopathy associated with predominant fibronectin deposits: A
newly recognized hereditary disease. A newly recognized type of familial
glomerulopathy observed in patients of both sexes in six families is
reported. Proteinuria, often within the nephrotic range, microscopic
hematuria, hypertension and a slowly decreasing renal function over
several years were common. No underlying systemic diseases were iden-
tified. Generally, light microscopy showed enlarged glomeruli with mini-
mal hypercellularity and with extensive deposits in the mesangium and
subendothelial space. By electron microscopy, granular deposits with some
admixture of fibrils were most common. In one family, the deposits were
predominantly fibrillary. Immunoglobulins and complement factors were
inconstant or lacking. A main finding was a strong immune reactivity to
fibronectin, corresponding to the distribution of the deposits. In one
patient, the deposits recurred in a renal transplant. There was no
indication of systemic deposition. Abnormalities in the metabolism of
circulating fibronectin may play a pathogenetic role in this disease of
probably autosomal dominant inheritance.
Renal biopsy specimens with uncommon morphological pat-
terns, not fitting into the established classifications of glomerular
diseases, are occasionally seen. Recent experience with collagen
type III glomerulopathy [1—3 ] has shown that it may be worth-
while to look for immune reactants other than immunoglobulins
and complement factors. A pattern of heredity is sometimes
apparent in such conditions [4—7]. Stimulated by our own expe-
rience with biopsies from two families with an unusual nephrop-
athy, we found four reports in the literature describing similar
morphology in an apparently familial renal disease. Mazzucco et
al [7] were the first to test for fibronectin (FN) deposits in renal
tissue from their patients. Accordingly, we examined the morpho-
logical and immunohistochemical alterations in patients from six
unrelated families with this form of glomerulopathy, In all avail-
able renal tissue from affected members, FN deposits were
identified in an uncommon and characteristic pattern.
Methods
Renal specimens from a total of 15 patients coming from six
families (A - F) were studied (by EHS and MJM). Six specimens
from two families (family A and B) were primarily investigated in
Basel, Switzerland. Material from nine patients from four other
families (C - F) previously reported [4—7] were reinvestigated.
Biopsy specimens were available from 12 patients, autopsy
material from two (case E-II-1 and F-III-2), and a nephrectomy
specimen with a renal cell carcinoma, from one (case F-hI-b).
For light microscopy (LM), formalin fixed specimens were
processed according to standard techniques. The LM sections
were stained with hematoxylin and eosin (HE), PAS, AFOG (acid
fuchsin orange G), congo red and silver methenamine. For
immunohistology (IH), frozen or formalin fixed material from
eight patients was investigated for immunoglobulins and comple-
ment factors by immunofluorescence (IF) according to standard
techniques or by the avidin biotin complex (ABC) elite technique
(Vector, Burlingame, VT, USA). For investigation of extracellular
matrix proteins, formalin fixed, paraffin embedded material from
nine patients was studied by the ABC technique, and frozen
material from two patients was investigated by immunofluores-
cence. Table 1 shows the antibodies applied. IST-4 detects all
fibronectins ("cellular" and "plasma-" FN), and IST-9 only FN
containing the extra domain A ("cellular FN") [8]. For optimal
immunostaining, the specimens required different dilutions of
antibodies, probably because of variation in fixation conditions.
Antibody against Source
Fibronectin (FN) Serotec
Fibronectin (IST-4)" L. Zardi [8]
Fibronectin (IST9)a L. Zardi [8]
Tenascin (Ten) DAKO
Laminin (Lam) Bio-Science
Collagen I (C I) Southern
Collagen III (C III) Southern
Collagen IV (C IV) DAKO
Table 1. Monoclonal antibodies for matrix proteins
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Table 2. Clinical findings
Immunostaining for matrix proteins was optimized by treating the
sections in a microwave oven and with pronase. Renal specimens
from conditions with abundant PAS positive homogenous depos-
its were used as control sections. Among these controls were one
case of cryoglobulinemia, rich in capillary "thrombi," one case of
focal segmental glomeruloscierosis with extensive hyalinosis and
many tubular casts, one case of severe cyclosporine-associated
arteriolopathy with abundant protein deposits in the arteriolar
walls, and two cases of membranoproliferative glomerulonephritis
(MPGN) type 1.
For EM, glutaraldehyde fixed specimens or material retrieved
from paraffin blocks were processed according to standard tech-
niques.
Unfortunately, extraction of the protein deposits from formalin
fixed kidneys to prepare Western blot analysis was unsuccessful.
Results
Clinical features
The clinical data from all 23 cases, including the previously
published ones, are summarized in Table 2, and the pedigrees of
the six families (A - F) are shown in Figure 1. Twenty-one patients
had proteinuria, five within the nephrotic range (more than 5
g/day). Microscopic hematuria was noted in 12 patients. Ten
patients suffered from hypertension. Serum creatinine was normal
or slightly elevated at the time of the first biopsy. Four patients
had normal renal function after ten and 18 months, five and seven
years follow-up, respectively. Six had slowly decreasing renal function
after two, six, nine, ten, 11 and 15 years, respectively. Five needed
dialysis after two to 13 years of clinical disease. Four patients were
transplanted, three had normal function at the end of observation, at
most 13 years after transplantation. The fourth transplanted patient
(F-III-8) had a biopsy proven relapse of deposits in the transplant [9].
One female (D-II-3) without renal disease (confirmed by biopsy with
EM) donated one kidney to her brother.
Three patients in one family had cerebrovascular hemorrhages
(CVH), two of which were fatal. The other patient with a CVH
died of a subsequent myocardial infarction. One patient commit-
ted suicide.
In none of the patients was there evidence of systemic lupus,
cryoglobulinemia, plasma cell dyscrasias, diabetes mellitus or
amyloidosis.
Follow-up information of renal function was not available in
five patients.
Light microscopy
The specimens from all patients showed slightly variable gb-
merular abnormalities. By low power magnification, the glomeruli
were enlarged and often lobulated. Higher magnification showed
Age
Sympt.
before bx
Cr
at bx
.Micro-
hematuria
. 0Proteinuria
at bx Hyper-
Last observation
Follow-up Cr
Patient Sex at bx months mg/dl at bx g/24 hr tension years mg/dl etc.
AI2a f 59 4 1.0 — 3.9 + 5 1.1
A-II-8" m 18 7 1.2 — 4.5 + 11 2.3
AlI10a m 24 108 1.0 + 14 — <1 0.9
BIII2a m 21 1.0 2-4 —
BIII3a m 19
BIIl5a f 22
C-I-2" f 25 36 — 5 — 15 1.8
CII1th f 14 36 0.6 nephrotic 4 0.9
D-I-l" m 64 — 1.1 + 2
D-II-1" m 16 + 5 + 2 dial native kidney
D-Il-2" m 23 — 0.8 + 0.6
7
7
normal
normal
tp
D-H-3" f 25 — 0.8 — 0.3 — kidney donor,
D-II-7'
D-Il-8"
m
m
30
24
96
weeks
1.3
1.4
+
+
2.1
1.3
+ 7
10
normal
dial
healthy
tp
E-II-1" f 26 72 — + + 6 3.6 dead (CVH)
E-II-2"
E-II-3"
m
m
29
15
36 1.8 +
—
3+
4+
+
+
9
7
13
1.8
dial
normal
dead (CVH)
native kidney
tp dead (CVH, MI)
E-III-2" m 14 weeks? 0.8 — 3+ + 10 2.8
F-Ill-i" m 44 6 1.6 + 4.7 + 2 1.5
F-III-2"
F-IlI-3"
f
m
37
33
48
12
0.9
1.0
+
+
0.7
1.0
—
—
4
1.5 normal
dead (suicide)
F-I1I-8" m 31 weeks 1.0 + 2.1 + 13
?
dial native kidney
tp (relapse)
F.1IIi0a m 53 144 + nephrotic 2 normal renal cell Ca.
Abbreviations are: bx, biopsy; CVH, cerebrovascular hemorrhage; Cr,
a Investigated in this study
"Previously published
plasma creatinine; dial, dialysis; MI, myocardial infarction; tp, transplant.
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Fig. 1. Pedigrees of six families with several members affected by the fibronectin glomerulopathy. Symbols are: () female with nephropathy; () male with
nephropathy.
enlargement of the mesangium and subendothelial space, mainly
due to a PAS positive deposition of homogenous material, which
stained brightly red in the AFOG stain (Fig. 2 and 3). In the silver
methenamine sections, the deposits were infrequently stained and
were outlined by a dark GBM (Fig. 4). Congo red staining was
negative in all cases. Most cases showed minimal or no hypercel-
lularity, whereas a few had a more pronounced increase in
mesangial cells and matrix. No mesangial cell interposition was
seen. Many capillary lumens were severely narrowed due to
thickening of the peripheral capillary walls. Glomeruli with less
severe involvement disclosed deposits mainly in the mesangium,
whereas in others the subendothelial space was also affected. Few
glomeruli were completely sclerosed. Glomeruli with signs of
advanced collapse often showed no deposits.
No significant abnormalities were seen in the tubulointerstitial
space. In the autopsy material, a slight to moderate interstitial
fibrosis was present. In some specimens, minimal arteriolar hya-
linosis was observed. In a careful review of paraffin slides from
lung, brain, heart, liver and spleen from patient F-III-2, no other
deposits were found [4].
Electron microscopy
EM confirmed the presence of the deposits seen by LM. In five
cases, massive homogenous granular osmiophilic deposits were
detected in the subendothelial space and in the mesangium (Fig.
5), corresponding to the distribution of the PAS positive material
seen by LM (Table 3). In some biopsies, translucent zones were
found within the deposits. In the two specimens from one family
(F), confluent areas of fibrils with a diameter of 14 to 16 nm were
seen (Fig. 6). Scattered fibrils of 12 nm were observed in material
from another family (illustrated in [7]). A few fibrils were seen in
most cases, but had to be looked for with great care. A moderate
increase in mesangial matrix was present in most cases, but the
mesangial enlargement was mainly due to the deposits, and less to
matrix increase. The deposits most often did not affect the lamina
densa. However, in one family (F), the fibrils were also observed
intramembranously and subepithelially (illustrated in [4]).
Immunohistology
Our findings concerning immunoglobulins and complement
factors were very sparse in six patients (Table 3). These findings
are similar if not identical with those cited in the literature of the
previously published cases. In two patients from family A, 1gM,
IgG, complement C3 and fibrinogen were more intensively posi-
tive with an unusual, diffuse pattern of staining (Fig. 7). In seven
patients, no IH for immunoglobulins was performed.
Immunostaining for matrix proteins (Table 3) tested in 11 cases
showed a very strong reaction for FN in nine and a weak reaction
in one, corresponding to the distribution of the electron dense
deposits seen by EM and the PAS positive material seen by LM
(Fig. 8). With antibodies recognizing isoforms of FN, performed
in nine cases, IST-4 was strongly positive (Fig. 9), while IST-9 was
weakly or focally positive. Interpretation of the IST-9 staining was
often difficult in the paraffin material because of strong back-
ground staining. Tenascin and collagen IV were expressed in the
mesangial stalk; however, the deposits were mostly negative.
(Figs. 10 and 11). In the material from two patients, a stronger
staining for tenascin and collagen IV was seen, which is probably
the result of a more extensive increase in mesangial matrix.
Laminin was expressed only in the GBM outlining the deposits
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Fig. 2. Patient F-Ill-JO. Homogenous PAS positive deposits in the me-
sangium and the subendothelial space. PAS X300.
(Fig. 12). Collagen I was weak or negative, and collagen III was
not detected in the deposits.
The deposits in the control sections did not show immune
reactivity to fibronectin, except for the two cases of MPGN, where
FN deposits were found at the site of complement or immuno-
globulin deposits in small amounts along the GBM.
Discussion
The clinical and morphological aspects of the six families
described here are to a large extent similar. Findings in four of
these families were previously reported to some extent [4—71. In
our study, we re-examined the kidney biopsies, compared the
findings from all families, and tested for matrix proteins by IH,
where material was available but had not previously been exam-
ined.
The disease appeared at different ages, mostly in early adoles-
cence. Proteinuria and a stable or slowly decreasing renal function
were common clinical features. Microscopic hematuria was
Fig. 3. Patient A-I-2. The protein deposits stain brightly red in the
trichrome stain. AFOG X300.
Fig. 4. Patient B-IlI-2. The mesangial and
subendothelial deposits show infrequent
staining with silver methenamine. The deposits
are outlined by the dark GBM. (X300).
present in most patients. Five patients developed end-stage renal
failure. Both sexes were affected in four families, and the disease
appeared in successive generations, suggesting an autosomal
dominant mode of inheritance (Fig. 1 A -F).As the symptoms are
nonspecific, the diagnosis can only be made by renal biopsy.
The overall impression by LM is that of MPGN. However, the
morphological pattern of enlarged glomeruli with extensive sub-
endothelial and mesangial deposits, often with an accentuated
lobular pattern without a clear-cut hypercellularity or mesangial
cell interposition, does not fit with the diagnosis of MPGN, nor
any other entity of the WHO classification of glomerular diseases.
However, in the case of type 1 MPGN there is obviously a
constant co-localization of FN with complement fraction and/or
immunoglobulins [1OJ.
Findings by EM were variable. Homogenous granular deposits
dominated in most cases. In some, an admixture of fibrils was
observed, but in most cases fibrils were scanty. In only one family
(F) were the deposits predominantly fibrillary. These fibrils had a
larger diameter than those of amyloid and were Congo red
er Sr iI4 C?
-. .,, tIflfi'tC"'?I
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: tvc:2
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Fig. 5. Patient A-lI-JO. Diffuse granular deposits in the subendothelial space and, to a lesser degree, in the mesangium. EM X 1717.
negative. The morphology differed from that described in fibril-
lary or immunotactoid glomerulopathy [11, 12], and there was no
reactivity to light chains, as previously determined for patients
E-II-1, E-III-2 and F-hI-b. Circulating ciyoglobulins were not
present in these patients. Therefore, we have no explanation for
the fibril formation other than the fact that fibronectin itself may
undergo fibril formation [13]. For comparison, granular deposits
are the major ultrastructural pattern in light chain deposition
disease; however, greater amounts of fibrillary structures may be
found in this disease [14]. It is possible that local glomerular
conditions or different physiochemical properties of the material
being deposited may favor more extensive fibril formation in one
or the other family.
The major findings by IH were the FN reactivity and the relative
absence of immunoglobulin deposition. The latter argues against
an immune complex mediated disease [7]. Of two patients belong-
ing to family E, not included in Table 3, one had diffuse mesangial
IgG and weaker staining for IgA, 1gM and C3. The other patient
Fig. 6. Patient F-Ill-JO. Fibrillary substructure of subendothelial deposits. had weak and focal staining for IgA, 1gM and C3 [6]. However, the
Material retrieved from paraffin block of nephrectomy specimen. EM intensity of the immunoglobulin and fibrinogen staining, espe-
x42,920. cially seen in family A, was diffuse and quite different from the
168 Strøm et al: Glomerulopathy and fibronectin deposits
Fig. 7. Patient A-II-8. Diffuse IgG immune
reactivity in the mesangium and the
subendothelial space (immunofluorescence
x250).
Table 3. Immunohistochemical and electron microscopic findings
Patient
Immunoglob.!
complement
Matrix proteins in deposits Deposits by EM
FN IST-4 IST-9 Ten C I C III C IV Lam Type Localization
A-I-2 G, M, C3, Clq, 3+ — (+) — (+) —
fibrinogen
A-II-8 (G, M, C3, 3+ + — — (+) — (+) — Granular mes/subendo
fibrinogen)
A-Il-b (M, Clq, C3) Granular mes/subendo
B-III-2 (G, C3) 3+ — — — (+) — Granular mes/subendo
B-III-3
B-III-5
C-I-2 (M, Clq, C3) 3+ + () a a Granular, few fibrils mes/subendo
C-TI-i (M, Clq, C3) 3+ + (+) a a Granular, few fibrils mes/subendo
D-II-3 No deposits
D-II-7 3+ + — 2+ — — 2+ (+) Granular mes/subendo
D-II-8 + + — (+) — — (+) — Granular mes/subendo
E-Il-1 3+ + (+) 2+ — — 2+ +
E-II-3 ? + — — — - 2+ (+)
F-III-2 (G, M, C3-5) 3+ + — — — — — — Fibrillar mes/subendo/subepi
F-hI-b (M, C3-5) 3+ + (+) — (+) — — — Fibrillar mes/subendo/subepi
Open fields: not performed. In brackets: weak staining
a Polyclonal antiserum, see [7].
pattern normally observed in immune complex glomerulonephri-
tis. One possible explanation for this reactivity may be that
circulating immunoglobulins undergo non-specific trapping in or
adsorption to the FN deposits [7]. A similar irregular co-deposi-
tion of immunoglobulins and complement factors may also be
found in amyloidosis, and this may reflect co-precipitation or
unspecific binding to amyloid fibrils. Mazzucco et al [7] were the
first to test for FN in this entity, and its presence was then
confirmed in the other cases presented here. Assmann, Koene and
Wetzels [151 have described similar findings by LM, IH and EM in
renal biopsies from a father and his son.
The FN reactivity corresponded to the distribution of the
electron dense deposits, with accumulation in the mesangium and
in the subendothelial space. The staining seemed to exceed the
mesangial matrix, which was slightly to moderately enlarged in
several cases. Moreover, tenascin was generally not expressed in
the deposits, but in the mesangial matrix, sometimes together with
collagen IV. FN, collagen IV and tenascin have been shown to be
co-expressed in the mesangium in several glomerular diseases
[16], all proteins probably being induced by transforming growth
factor-a [17—20]. The lack of co-expression with tenascin in the
deposits in our patients argues against FN being locally produced.
Of further note is that the deposits stained positively for IST-4
and only faintly for IST-9, suggesting that most of the FN is
plasma-derived and not locally synthesized [7, 8]. However, since
the IST-9 staining was difficult to interpret on paraffin material,
this reactivity needs further study on fresh material. In further
support of a circulating FN being deposited is the fact that the
I /
I,
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Fig. 8. Patient F-IH-2. Strong immune reactivity to fibronectin (Serotec) Fig. 9. Patient E-lI-1. Strong immune reactivity to fibronectin IST-4 in the
in the mesangial and subendothelial deposits (X300). deposits (X300).
Fig. 10. Patient E-II-1. The deposits show infrequent immune reactivity to Fig. 11. Patient F-Ill-JO. No immune reactivity to collagen IV in the
tenascin, while the mesangial matrix is positive (x300). deposits, while the mesangial matrix is positive (x300).
deposits, although not tested for FN, have recurred in a transplant
in a member of one family described herein [9]. Of note is our
finding that in collapsed, hypoperfused glomeruli, no FN deposits
were found, which also favors a circulating factor being deposited.
Despite some variations, the morphological pattern was quite
similar in the families A through C. Family F differs by the
presence of extensive fibrils. In families D and E, a mesangial
involvement predominated. These patients had a more pro-
nounced increase in mesangial matrix, supported by a stronger
and more widely distributed immune reactivity to tenascin and
collagen IV. However, in these cases subendothelial deposits were
also present.
No extrarenal deposits were found in the patients in which
autopsy was performed [4, 61.
The significance of the FN reactivity is uncertain. FN is found
Fig. 12. Patient F-IfI-2. No immune reactivity to laminin in the deposits. in extracellular matrix, and is an adhesive high molecular weight
The GBM is clearly positive (x300). glycoprotein. It takes part in cellular proliferation, wound healing,
V j4;#
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phagocytosis and platelet aggregation [8, 21]. It is present in the
mesangial matrix of normal glomeruli, and shows increased
expression in several types of glomerular diseases [10, 22, 23],
probably owing to local production by mesangial and glomerular
epithelial cells [19, 24]. In our patients, however, we have indica-
tions that most of the FN observed is not part of or produced in
the mesangium.
For our study only formalin fixed material was available. This
precluded us from performing a reliable Western blot analysis to
further identify the nature of the glomerular deposits. Therefore,
we do not know if FN is the sole or main protein in the deposits,
or a "passenger" linked to another protein being deposited. An
isoform of FN is normally present in plasma ("plasma-FN"). As
for other high molecular weight molecules, plasma-FN is found to
be elevated in patients with severe proteinuria [25], probably due
to increased synthesis compensating for the loss of albumin.
Plasma FN levels have previously been tested in only two of our
patients, and was found by Western blot analysis to be similar to
that of healthy controls [7]. We do not know whether the
deposited FN has an abnormal structure. On the other hand, we
are not aware of any familial disease with abnormal levels of
circulating FN. As metalloproteinases and their tissue inhibitors
(TIMPs) are important in the degradation of FN and other matrix
proteins [26], changes in the metabolism of these enzymes may
possibly play a role in this disease.
A co-operative clinico-genetic study between the clinicians in
charge of surviving members of the described families is now
under way, and will hopefully contribute to the understanding of
the pathogenesis of this nephropathy.
Reprint requests to Prof M.J. Mihatsch, Institute for Pathology, University
of Basel, Schonbeinstrasse 40, CH-4003 Base!, Switzerland.
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